Position in CRSP
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$7,777,513
+$241,664 QoQ
Shares Held
142,602
-10.0% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#51
of 521 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. CRSP ranks #29 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in CRSP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,777,513 | 142,602 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $7,535,849 | 158,416 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,307,335 | 158,416 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $11,316,862 | 174,616 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,110,154 | 228,416 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $8,246,149 | 242,320 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $9,463,875 | 240,444 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,500,075 | 159,644 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $8,622,372 | 159,644 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $11,368,679 | 166,794 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $14,138,961 | 225,862 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $10,914,570 | 240,462 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $11,962,030 | 213,075 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,498,571 | 210,006 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $7,391,267 | 181,827 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $7,534,266 | 115,291 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $6,299,478 | 103,661 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,010,209 | 32,025 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,597,207 | 34,273 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,402,336 | 30,397 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,920,970 | 30,397 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,825,602 | 31,396 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,854,811 | 31,708 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||